CSat Investment Advisory’s Boston Scientific BSX Stock Holding History

CSat Investment Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$15K	Buy	384 +22	+6%	+$833	0.01%	408
2020 Q4	$13K	Sell	362 -8,610	-96%	-$310K	0.01%	401
2020 Q3	$343K	Buy	8,972 +660	+8%	+$25.4K	0.03%	206
2020 Q2	$292K	Buy	8,312 +981	+13%	+$35.3K	0.04%	245
2020 Q1	$240K	Buy	7,331 +2,467	+51%	+$96.4K	0.05%	212
2019 Q4	$220K	Buy	4,864 +1,244	+34%	+$52.1K	0.06%	224
2019 Q3	$148K	Buy	3,620 +366	+11%	+$15.5K	0.05%	253
2019 Q2	$140K	Buy	3,254 +3,119	+2,310%	+$120K	0.05%	237
2019 Q1	$5K	Sell	135 -8	-6%	-$306	﹤0.01%	496
2018 Q4	$5K	Buy	143 +26	+22%	+$943	﹤0.01%	480
2018 Q3	$5K	Sell	117 -6	-5%	-$210	﹤0.01%	459
2018 Q2	$4K	Buy	+123	New	+$3.71K	﹤0.01%	471

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

CSat Investment Advisory's BSX Position: Q1 2021 in Review

CSat Investment Advisory increased its Boston Scientific (BSX) stake by 6.1% in Q1 2021, buying an estimated $833 and bringing the position to 384 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #408.

CSat Investment Advisory first reported a position in BSX in Q2 2018 and has held it in 12 quarters since. The position peaked at $343K in Q3 2020. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

CSat Investment Advisory held 384 shares of Boston Scientific worth $15K as of Q1 2021.
CSat Investment Advisory bought 22 Boston Scientific shares in Q1 2021, an estimated $833.
Boston Scientific made up 0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #408 holding.
CSat Investment Advisory first reported a position in Boston Scientific in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's Boston Scientific position peaked at $343K in Q3 2020.
831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.